Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
migraine
Pharma
Lundbeck stays positive on Rexulti PTSD use despite adcomm vote
There’s a high medical need in PTSD as the last FDA approval in the field was 23 years ago, Lundbeck's R&D chief noted on an investor call.
Angus Liu
Aug 15, 2025 10:50am
Teva forecasts $5B-plus in innovative drug sales by 2030
May 30, 2025 7:20am
Axsome secures hard-fought FDA nod for migraine drug Symbravo
Jan 31, 2025 8:18am
Pfizer pays $60M to resolve Biohaven's Nurtec kickback claims
Jan 27, 2025 10:39am
AbbVie names first Migraine Career Catalyst Award winners
Nov 15, 2024 2:58pm
BMJ says newer migraine drugs less effective than older triptans
Sep 19, 2024 11:32am
